CHK1-IN-3
CHK1-IN-3 is a potent and selective CHK1 inhibitor with an IC50 of 0.4 nM. CHK1-IN-3 effectively inhibits the growth of malignant hematopathy cell lines and displays low affinity for hERG (IC50 > 40 μM) . CHK1-IN-3 significantly suppresses the tumor growth in vivo. CHK1-IN-3 can be used for the study of hematologic malignancies[1].
Product Specifications
CAS Number
2097252-39-4
UNSPSC
12352005
Target
Checkpoint Kinase (Chk)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/chk1-in-3.html
Purity
99.79
Solubility
DMSO : ≥ 125 mg/mL
Smiles
CNC1=C(C2=CN(C)N=C2)C=NC(NC3=CN=C(C#N)C(O[C@H]4CNCCC4)=C3)=N1
Molecular Formula
C20H23N9O
Molecular Weight
405.46
References & Citations
[1]Tong L, et al. Discovery of (R) -5- ((5- (1-methyl-1H-pyrazol-4-yl) -4- (methylamino) pyrimidin-2-yl) amino) -3- (piperidin-3-yloxy) picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies. Eur J Med Chem. 2019 Jul 1;173:44-62.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Chk1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC224096L3V 200 µL
PPP1R12C (NM_017607) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details LV695015 1.0 µg DNA
AVPR2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details 
19022-01 25 g
5,7-Diiodo-8-Quinolinol (Diiodohydroxyquinoline, Iodoquinol) ExiPlus, 96.5%
Sign In for Pricing
View Details 19022-02 100 g
5,7-Diiodo-8-Quinolinol (Diiodohydroxyquinoline, Iodoquinol) ExiPlus, 96.5%
Sign In for Pricing
View Details 19022-03 500 g
5,7-Diiodo-8-Quinolinol (Diiodohydroxyquinoline, Iodoquinol) ExiPlus, 96.5%
Sign In for Pricing
View Details